DexCom (DXCM)
(Delayed Data from NSDQ)
$111.94 USD
-0.19 (-0.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $112.03 +0.09 (0.08%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 281 - 300 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Q2 results ahead, guidance raised, maintain SELL on valuation, PT to $28.50
Provider: FELTL & COMPANY
Company: DexCom, Inc.
Industry: Medical - Instruments
2Q14 Very Strong Across the Board; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Quarter Preview: Expecting a Top-Line Beat; Maintain OUTPERFORM, $48 PT
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
CGM Project: Historical survey of 1,271 CGM users (2007 - present)
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
2Q Preview: Expecting Trends to Improve (Slightly)
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Perspectives on the Largest Acquisition in MedTech: A Covidien Primer
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Perspectives on the Largest Acquisition in MedTech: A Covidien Primer
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Another Solid Top-Line Performance, But Stock-Based Compensation Weighs on Opex
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 sales inline with preannouncement, EPS ahead, advise profit taking
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Growth and Opportunity Continues on Pace; Price Target to $50
Provider: The Benchmark Company
Analyst: WALD J
Company: DexCom, Inc.
Industry: Medical - Instruments
Morning Call
Provider: The Benchmark Company
Company: DexCom, Inc.
Industry: Medical - Instruments
4Q13 Review: Raising Estimates and PT to $48; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.